Ipb Halle maintains a narrowly scoped software portfolio centered on the MolecularFaces product line, which appears to serve specialized scientific or research applications with a limited deployment footprint. The vendor's observed vulnerability surface reflects application-layer exposures without a dominant structural pattern. Current severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Ipb Halle over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2024-0758MEDIUM MolecularFaces before 0.3.0 is vulnerable to cross site scripting. A remote attacker can execute arbitrary JavaScript in the context of a victim browser via crafted molfiles. | Jan 19, 2024 | 6.1 | 20 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Ipb Halle.
Media articles that mention a CVE ID that affects a product developed by Ipb Halle — matched by CVE ID, not by vendor name.